BEAM

$30.08-0.62 (-2.02%)

After Hours$30.29+0.21 (+0.70%)· Last close May 4

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO